Early Research Suggests GLP-1 Drugs May Slow Aging by Two to Four Years
Novo Nordisk and Eli Lilly presented findings that their GLP-1 drugs may slow certain biological signs of aging by two to four years.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.